NeuroMetrix, Inc. (NURO)
4.58
0.00 (0.00%)
USD |
NASDAQ |
Jun 26, 16:00
NeuroMetrix Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2024 | -7.128M |
| September 30, 2024 | -6.689M |
| June 30, 2024 | -6.958M |
| March 31, 2024 | -7.045M |
| December 31, 2023 | -6.085M |
| September 30, 2023 | -6.117M |
| June 30, 2023 | -6.283M |
| March 31, 2023 | -5.670M |
| December 31, 2022 | -5.289M |
| September 30, 2022 | -4.319M |
| June 30, 2022 | -3.084M |
| March 31, 2022 | -2.780M |
| December 31, 2021 | -2.074M |
| September 30, 2021 | -1.28M |
| June 30, 2021 | -0.8038M |
| March 31, 2021 | -1.338M |
| December 31, 2020 | -2.067M |
| September 30, 2020 | -2.409M |
| June 30, 2020 | -3.631M |
| March 31, 2020 | -4.805M |
| December 31, 2019 | -3.621M |
| September 30, 2019 | -4.282M |
| June 30, 2019 | -2.157M |
| March 31, 2019 | 1.202M |
| December 31, 2018 | 2.862M |
| Date | Value |
|---|---|
| September 30, 2018 | 0.4107M |
| June 30, 2018 | -2.845M |
| March 31, 2018 | -7.218M |
| December 31, 2017 | -12.65M |
| September 30, 2017 | -13.10M |
| June 30, 2017 | -13.90M |
| March 31, 2017 | -14.82M |
| December 31, 2016 | -15.08M |
| September 30, 2016 | -14.94M |
| June 30, 2016 | -14.71M |
| March 31, 2016 | -14.07M |
| December 31, 2015 | -13.10M |
| September 30, 2015 | -11.94M |
| June 30, 2015 | -10.42M |
| March 31, 2015 | -8.714M |
| December 31, 2014 | -7.678M |
| September 30, 2014 | -6.579M |
| June 30, 2014 | -6.337M |
| March 31, 2014 | -6.361M |
| December 31, 2013 | -6.555M |
| September 30, 2013 | -7.540M |
| June 30, 2013 | -8.211M |
| March 31, 2013 | -8.392M |
| December 31, 2012 | -9.176M |
| September 30, 2012 | -8.409M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Abbott Laboratories | 9.464B |
| Aethlon Medical, Inc. | -6.998M |
| ABVC BioPharma, Inc. | -3.341M |
| Adagio Medical Holdings, Inc. | -15.93M |
| Autonomix Medical, Inc. | -12.28M |